Southern Texas again prescribes brand-name drugs in unusually high rates, as do Mississippi, South Florida and most of New Jersey.
The lack of uniform national guidelines and the still strong impact of pharmaceutical industry marketing continue favoring the rise in prescribing brand name antidepressants and antipsychotics.
Some authors suggest restrictions in prescribing brand name and newer antidepressants in order to increase the use of generic antidepressants, as a stimulating measure to modify prescribing habits [ 4].
At the main teaching hospital in Kathmandu, psychiatrists are trained to prescribe brand name drugs, rather than writing generic names, with the rationale that in the market place, and with increasing numbers of brands coming and going, this was the best way to be sure of the quality of the drugs.
Although a generic drug is therapeutic equivalent to the brand name one and is of the same quality, safety and efficacy as the brand name drug, the higher rate of prescribing brand name, more expensive drugs relies on the studies suggesting that even minimal variation in drug bioequivalence and efficacy may play a major role due to the complex nature of the disease [ 21, 22].
According to sales figures, in 2014 it was the 38th most prescribed branded drug in the US.
The plan saves Mr. Livert and other Nassau residents about 20percentt on commonly prescribed brand-name and generic drugs sold in independent and chain pharmacies in Nassau and throughout the country.
Nevertheless, thanks to a relentless advertising campaign in professional journals, regular visits by Shire drug reps to doctors' offices, and a barrage of professional medical educational speakers on the benefits of this new preparation, Adderall quickly passed Ritalin as the most frequently prescribed brand-name stimulant drug in America.
The extent of such involvement was higher among physicians who prefer to ask PRs for information when a new medication becomes available, physicians who are not satisfied with patient encounters ending only with advice, and physicians who prefer to prescribe brand-name medications.
The mean Promotional Activity Index Scores were slightly but statistically significantly higher among physicians who prefer to ask PRs for information about a new medication, those who are not satisfied with patient encounters ending only with advice, and those who prefer to prescribe brand-name medications.
The extent of involvement in promotional activities was greater among physicians who prefer to ask PR for information when a new medication becomes available, physicians who are not satisfied with the patient encounter ending only with advice, and physicians who prefer to prescribe brand-name medications when generic options are available (Table 3).
